Analysis of survival data with nonproportional hazard functions

Controlled Clinical Trials

Volumn 2, Issue 2, 1981, Pages 149-159

  Stablein, Donald M ^a   Carter Jr , Walter H ^a   Novak, Joel W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

hazard function; log rank test; survival data; time by treatment interactions

Indexed keywords

CLINICAL TRIAL; METHODOLOGY; STATISTICS; SURVIVAL RATE;

CLINICAL TRIALS; HUMAN; NEOPLASMS; RISK; STATISTICS; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0019723902     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-2456(81)90005-2     Document Type: Article

References (20)

1. Design and analysis of randomized clinical trials requiring prolonged observation of each patient
2. Design and analysis of randomized clinical trials requiring prolonged observation of each patient
3. Evaluation of survival data and two new rank order statistics arising in its consideration
4. Analysis of survival data under the proportional hazards model
5. Regression models and life tables
6. Asymptotically efficient rank invariant test procedures
7. Modified Kolmogorov-Smirnov test procedures with application to arbitrarily right censored data
8. Cytotoxics and hyperthermic perfusion: a preliminary study
9. Chemo-immuno therapy with levamisole in metastic breast carcinoma: a controlled clinical trial
10. On the use of indicator variables for studying the time-dependence of parameters in a response-time model
11. A logistic regression analysis of response-time data where the hazard function is time dependent
12. Chi-square goodness of fit tests for the proportional hazards model
13. Nonparametric estimation from incomplete observations
14. Proportional hazard regression models and the analysis of censored survival data
15. Survival analysis of drug combinations using a hazards model with time dependent covariates
16. A randomized trial of combined modality therapy (5,000 R + 5-FU + MeCCNU) versus combination chemotherapy (5-FU + MeCCNU) in treatment of locally unresectable gastric carcinoma
17. A qualitative discrepancy between censored data rank tests